1. Home
  2. KRUS vs NTLA Comparison

KRUS vs NTLA Comparison

Compare KRUS & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRUS
  • NTLA
  • Stock Information
  • Founded
  • KRUS 2008
  • NTLA 2014
  • Country
  • KRUS United States
  • NTLA United States
  • Employees
  • KRUS N/A
  • NTLA N/A
  • Industry
  • KRUS Restaurants
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • KRUS Consumer Discretionary
  • NTLA Health Care
  • Exchange
  • KRUS Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • KRUS 1.1B
  • NTLA 1.2B
  • IPO Year
  • KRUS 2019
  • NTLA 2016
  • Fundamental
  • Price
  • KRUS $81.46
  • NTLA $12.06
  • Analyst Decision
  • KRUS Buy
  • NTLA Buy
  • Analyst Count
  • KRUS 9
  • NTLA 20
  • Target Price
  • KRUS $94.56
  • NTLA $32.30
  • AVG Volume (30 Days)
  • KRUS 225.4K
  • NTLA 4.2M
  • Earning Date
  • KRUS 11-05-2025
  • NTLA 08-07-2025
  • Dividend Yield
  • KRUS N/A
  • NTLA N/A
  • EPS Growth
  • KRUS N/A
  • NTLA N/A
  • EPS
  • KRUS N/A
  • NTLA N/A
  • Revenue
  • KRUS $269,327,000.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • KRUS $20.49
  • NTLA $8.32
  • Revenue Next Year
  • KRUS $20.15
  • NTLA N/A
  • P/E Ratio
  • KRUS N/A
  • NTLA N/A
  • Revenue Growth
  • KRUS 18.76
  • NTLA 14.99
  • 52 Week Low
  • KRUS $40.03
  • NTLA $5.90
  • 52 Week High
  • KRUS $110.66
  • NTLA $23.76
  • Technical
  • Relative Strength Index (RSI)
  • KRUS 49.35
  • NTLA 60.10
  • Support Level
  • KRUS $79.60
  • NTLA $11.29
  • Resistance Level
  • KRUS $87.99
  • NTLA $12.46
  • Average True Range (ATR)
  • KRUS 3.49
  • NTLA 0.56
  • MACD
  • KRUS 0.41
  • NTLA 0.12
  • Stochastic Oscillator
  • KRUS 45.99
  • NTLA 84.85

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: